ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,666.40
      -2.25%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.11
      0.07%
      Bitcoin
      57,370.71
      -0.67%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Contravir Pharmaceuticals (MM) (CTRV)

      7. Contravir Pharmaceuticals (MM) (CTRV) News

      CTRV

      Contravir Pharmaceuticals Inc (CTRV)

      Contravir Pharmaceuticals (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CTRV
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      02/22/201810:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/22/20188:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric P...NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/21/20185:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/21/20185:11PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/21/20184:30PMGlobeNewswire Inc.ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until March 9, 2018NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/12/201811:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/12/20186:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals Reaches Agreement with the FDA on the NDA Package for TXL™ Leveraging the 505(b)(2) Regulatory Pa...NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/09/20188:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/09/20186:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals to Present at BIO CEO & Investor ConferenceNASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/06/20189:57AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/06/20186:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals Completes Renal Impairment Study with TXL™NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/05/20188:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      02/05/20187:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals Receives Positive Nasdaq Listing DeterminationNASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/25/20188:56AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/23/20186:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals to Present at NobleCon14NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/12/20185:13PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/05/20181:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/05/20181:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/05/20181:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/03/201811:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/02/201810:30AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      01/02/20186:00AMGlobeNewswire Inc.ContraVir Pharmaceuticals to Present at Biotech Showcase 2018NASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/29/20174:00PMGlobeNewswire Inc.ContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical OfficerNASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/21/20175:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/18/20175:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/13/20174:21PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/13/20174:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/13/20174:00PMGlobeNewswire Inc.ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until December 21, 2017NASDAQ:CTRVContravir Pharmaceuticals (MM)
      12/08/20175:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
       Showing the most relevant articles for your search:NASDAQ:CTRV